||Medable Achieves 400% Growth in First Half 2020, Expands Ecosystem for Decentralized Clinical Trials | Business Wire
||... areas, including oncology, dermatology, neurology, endocrinology and antivirals. “COVID-19 has accelerated decentralized trial adoption by five years,” said Dr. Michelle Longmire , CEO and co-founder of Medable. “We’re impressed with how quickly pharma and ... additional investment from existing investor PPD, Inc. Launched a mobile TeleVisit application , co-developed and deployed with PPD, to enable continued clinical research in light of COVID-19 concerns. TeleVisit connects patients virtually with site ...
||Medable Releases Global TeleVisit Capabilities to Enable Continued Clinical Trial Research in Light of Growing COVID-19 Concerns | Business Wire
||PALO ALTO, Calif.- In response to the global COVID-19 pandemic, Medable has developed a new TeleVisit mobile application that can be used by patients worldwide to connect virtually with their clinical trial sites. The ... participants while also enabling research to move forward,” said Dr. Michelle Longmire, Co-Founder and CEO of Medable. “There are more than 50,000 active clinical trials underway. These studies are extremely important and many have ...